36
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Myeloperoxidase Release After Allergen‐Specific Conjunctival Challenge

, , , , , , , & show all
Pages 639-643 | Published online: 26 Aug 2009

References

  • Sub‐committee on skin tests of the EAACI: skin tests used in type I allergy testing. Position paper. Allergy 1989; 44(suppl 10)1–59, [CSA]
  • Ciprandi G, Buscaglia S, Pesce G P, Passalacqua G, Rihoux J P, Bagnasco M, Canonica G W. Cetirizine reduces inflammatory cell recruitment and ICAM‐1/CD54 expression on conjunctival epithelium both in early and late phase events following allergen specific challenge. J Allergy Clin Immunol 1995; 95: 612–621, [PUBMED], [INFOTRIEVE], [CSA]
  • Friedlander M H. Ocular allergy. Allergy: Principles and Practice, E Middleton, C E Reed, E F Ellis, N F Adkinson, J W Younginger, W W Busse. Mosby, St. Louis 1993; 1649–1660
  • Ciprandi G, Buscaglia S, Pronzato C, Benvenuti C, Cavalli E, Bruzzone F, Canonica W. Oxotamide reduces inflammatory events induced by allergen‐specific conjunctival challenge. Ann Allergy, Asthma, & Immun 1995; 75: 446–452, [CSA]
  • Ciprandi G, Buscaglia S, Catrullo A, Paolieri F, Riccio A M, Fiorino N, Canonica G W. Antiallergic activity of topical lodoxamide on in vivo and in vitro models. Allergy 1996; 51: 946–951, [PUBMED], [INFOTRIEVE], [CSA]
  • Nordic Council of Medicines. Guidelines for the Registration of Allergen Preparations. Nordic Council of Medicines, UppsalaSweden 1980
  • Abelson M D, Chambers W A, Smith L M. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990; 108: 84–88, [PUBMED], [INFOTRIEVE]
  • Leonardo A, Borghesan F, Avarello A, Plebani M, Secchi A G. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol 1997; 81: 23–26
  • Truong M J, Gruart V, Kusnierz J P, Papin J P, Loiseau S, Capron A, Capron M. Human neutrophils express immunoglobulin E (IgE)‐binding proteins (Mac2/εBP) of the S‐type lectin family: role in IgE‐dependent activation. J Exp Med 1993; 117: 243–248, [CROSSREF]
  • Monteseirín J, Camacho M J, Montaño R, Llamas E, Conde M, Carballo M, Guardia P, Conde J, Sobrino F. Enhancement of antigen‐specific functional responses by neutrophils from allergic patients. J Exp Med 1996; 183: 2571–2579, [CROSSREF]
  • Collison K S, Kwaasi A A, Parhar R S, al‐Sedairy S T, al‐Mohanna F A. Monomeric human IgE evokes a transient calcium rise in individual human neutrophils. J Leukoc Biol 1995; 58: 459–467, [PUBMED], [INFOTRIEVE], [CSA]
  • Carlson M, Håkansson L, Peterson Ch, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87: 27–33, [PUBMED], [INFOTRIEVE], [CSA]
  • Keatings V M, Barnes P J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449–453, [PUBMED], [INFOTRIEVE], [CSA]
  • Jacobi H H, Poulsen L K, Reimert C M, Skov P S, Ulfgren A K, Jones I, Elfman L B, Malling H J, Mygind N. IL‐8 and the activation of eosinophils and neutrophils following nasal allergen challenge. Int Arch Allergy Immunol 1998; 116: 53–59, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Palczynski C, Krakowiak A, Ruta U, Krajewska B, Rudzinski J, Gielec L, Górski P. Nasal response to allergen challenge in patients with immediate asthmatic reaction. Allergol Immunopathol 1996; 24: 163–168, [CSA]
  • Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi A G, Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129: 151–158, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Rak S, Björnson A, Håkanson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991; 88: 878–888, [PUBMED], [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.